<DOC>
	<DOCNO>NCT01387724</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research trial study biomarkers blood tissue sample patient newly diagnose neuroblastoma .</brief_summary>
	<brief_title>Biomarkers Blood Tissue Samples From Patients With Newly Diagnosed Neuroblastoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine expression neuropeptide Y ( NPY ) receptor ( Rs ) human neuroblastoma ( NB ) tissue . - Determine whether BDNF/TrkB TrkAIII stimulate expression NPY Rs . - Determine whether NPY mediate BDNF- TrkAIII-induced NB proliferation survival . - Determine neurotrophins ' angiogenic action . - Identify factor release NB cell upon NPY stimulation ( proteomics ) . - Determine whether NPY upregulates expression identify protein NB Rs endothelial cell ( ECs ) . - Test whether inhibition identify pathway reduces angiogenic activity NB-conditioned medium . - Determine mechanism NYP action signal pathway . - Test whether block NPY-Y2/Y5 pathway reduces NB growth vascularization vivo . OUTLINE : Archived tumor tissue serum sample analyze neuropeptide Y receptor ( Y1 , Y2 , Y5 ) expression , neuroblastoma prognostic factor ( MYCN , TrkA , TrkAIII , TrkB , BDNF , NGF ) , angiogenic marker real-time PCR , IHC , ELISA , radioimmunoassay ( RIA ) , mitogenic assay , caspase 3/7 activity assay , western blot , liquid chromatography , tandem mass spectrometry , proteomic assay , assay . Results analyze compare patient ' clinical data , include stage disease , phenotype , prognostic marker , age gender , response treatment .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Children newly diagnose neuroblastoma ganglioneuroblastoma Samples Children 's Oncology Group ( COG ) patient enrol clinical trial institution USA , Canada , Australia Paraffinembedded tumor specimen , RNA isolate tumor tissue , patient serum must available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>localize resectable neuroblastoma</keyword>
	<keyword>localize unresectable neuroblastoma</keyword>
	<keyword>regional neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
</DOC>